Radiation before chemo and immunotherapy shows promise for tough lung cancers

NCT ID NCT06800339

Recruiting now Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests whether adding a short course of high-dose radiation before standard chemotherapy and immunotherapy can help shrink borderline resectable non-small cell lung cancer before surgery. About 18 adults with stage II to IIIC lung cancer will receive three doses of radiation, then up to three cycles of chemo plus nivolumab, followed by surgery if possible. The main goal is to see if this combination is safe and tolerable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Baltimore Washington Medical Center- Tate Cancer Center
RECRUITING

Glen Burnie, Maryland, 21061, United States
Maryland Proton Treatment Center
RECRUITING

Baltimore, Maryland, 21201, United States
University of Maryland Greenebaum Cancer Center
RECRUITING

Baltimore, Maryland, 21201, United States
Upper Chesapeake- Kaufman Cancer Center
RECRUITING

Bel Air, Maryland, 21014, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.